Synergy Rx Recalls QUAD PEEL Due to Sterility Assurance Concerns
Synergy Rx is recalling QUAD PEEL chemical peels nationwide due to a lack of assurance of sterility and CGMP deviations.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric, particularly given the risk of infection associated with a lack of sterility assurance in a topical chemical peel.
Plain-English summary
Synergy Rx is voluntarily recalling all lots of QUAD PEEL, a prescription-only chemical peel product containing Sal Acid 2%, TCA 7%, Phenol 7%, and Retinoic acid 0.4%. The recall is being conducted because the product lacks assurance of sterility and the manufacturer has identified Current Good Manufacturing Practice (CGMP) deviations.
The affected product was distributed nationwide within the United States. The recall covers all lots of the product. No specific dates or quantities are provided in the source text.
Consumers and healthcare providers with this product should stop using it and contact Synergy Rx at (855) 792-6676 for further instructions or a refund.
The recalled product
- Product
- QUAD PEEL (Sal Acid 2%, TCA 7%, Phenol 7%, Retinoic acid 0.4%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676
- Manufacturer
- Synergy Rx
- Category
- Drug — Topical Chemical Peel
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 81 recalled by Synergy Rx under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 81 products in this recall →Related recalls
Same manufacturer · Synergy Rx
See all →- SevereSynergy Rx Recalls Lidocaine Creams Due to Sterility Assurance Issues
FDA (Drugs) · 2017-03-22
- HighSynergy Rx Recalls Ultra Lite Cream Due to Sterility Concerns
FDA (Drugs) · 2017-03-22
- SevereSynergy Rx Recalls Lactic Acid Solution Due to Sterility Concerns
FDA (Drugs) · 2017-03-22
- HighSynergy Rx Modified Jessner Peel Recalled for Sterility Assurance Issues
FDA (Drugs) · 2017-03-22
- SevereSynergy Rx Recalls CLEAR 2 Due to Sterility Assurance Concerns
FDA (Drugs) · 2017-03-22
Same hazard · infection
See all →- SevereStryker Bard EP XT Decapolar Steerable Diagnostic EP Catheter Recalled for Sterile Barrier Breach
FDA (Devices) · 2026-10-14
- SevereSafeguard US Operating LLC Recalls Compression Bandages Due to Degradation
FDA (Devices) · 2026-10-14
- HighEmbosphere Microspheres Recalled Due to Packaging Sterility Concerns
FDA (Devices) · 2026-10-07
- SevereAurolab Trust Recalls FOCUS PI Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2026-10-07
- HighFDA Recalls Defective Blue Nitrile Patient Examination Gloves
FDA (Devices) · 2026-10-07
Similar recalls
- SeverePhenol Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2014-01-22
- HighFDA Recalls Fentanyl Syringes Due to Sterility Validation Concerns
FDA (Drugs) · 2023-08-09
- SevereRXQ Compounding Recalls Phenylephrine Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- HighFentanyl injectable product recalled for lack of sterility assurance
FDA (Drugs) · 2023-10-11
- HighPHENYLephrine Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2024-04-03
- HighFentanyl Injectable Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11